{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05268289",
            "orgStudyIdInfo": {
                "id": "CLNP023K12201"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-002046-33",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Novartis",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Effectiveness and Safety of LNP023 in Patients With Active Lupus Nephritis Class III-IV, +/- V",
            "officialTitle": "An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Mid-phase Trial to Evaluate the Effectiveness, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Kidney Involvement in Lupus Class III-IV, +/- V",
            "therapeuticArea": [
                "Immunology and Rheumatology"
            ],
            "study": "study-of-effectiveness-and-safety-of-in-patients-with-active-lupus-nephritis-class-iii-iv-v"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-24",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-03-13",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-24",
            "studyFirstSubmitQcDate": "2022-02-24",
            "studyFirstPostDateStruct": {
                "date": "2022-03-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Novartis Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The overall purpose of this two-part study is to assess the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.",
            "detailedDescription": "The overall purpose of this two-part study is to assess the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Lupus Nephritis"
            ],
            "keywords": [
                "LNP023",
                "Iptacopan",
                "Lupus Nephritis",
                "proteinuria",
                "Urine Protein-to-Creatinine Ratio",
                "complete renal response",
                "estimated glomerular filtration rate",
                "renal flares",
                "Systemic Lupus Erythematosus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 240,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Iptacopan + standard of care (part 1)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Iptacopan + standard of care",
                    "interventionNames": [
                        "Drug: Iptacopan (part 1)"
                    ]
                },
                {
                    "label": "Placebo matching iptacopan + standard of care (part 1)",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo matching iptacopan standard of care",
                    "interventionNames": [
                        "Drug: Placebo + standard of care"
                    ]
                },
                {
                    "label": "Iptacopan + standard of care (part 2)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Iptacopan + standard of care",
                    "interventionNames": [
                        "Drug: Iptacopan (part 2)"
                    ]
                },
                {
                    "label": "Iptacopan + placebo (part 2)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Iptacopan + placebo standard of care",
                    "interventionNames": [
                        "Drug: Iptacopan + placebo"
                    ]
                },
                {
                    "label": "Placebo matching iptacopan + standard of care (part 2)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Placebo matching iptacopan + standard of care",
                    "interventionNames": [
                        "Drug: Placebo + standard of care"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Iptacopan (part 1)",
                    "description": "Taken for 52 Weeks",
                    "armGroupLabels": [
                        "Iptacopan + standard of care (part 1)"
                    ],
                    "otherNames": [
                        "LNP023"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Iptacopan (part 2)",
                    "description": "Taken for 52 Weeks",
                    "armGroupLabels": [
                        "Iptacopan + standard of care (part 2)"
                    ],
                    "otherNames": [
                        "LNP023"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo + standard of care",
                    "description": "Taken for 52 Weeks",
                    "armGroupLabels": [
                        "Placebo matching iptacopan + standard of care (part 1)",
                        "Placebo matching iptacopan + standard of care (part 2)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Iptacopan + placebo",
                    "description": "Taken for 52 Weeks",
                    "armGroupLabels": [
                        "Iptacopan + placebo (part 2)"
                    ],
                    "otherNames": [
                        "LNP023 and placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Part 1 and 2: Proportion of patients achieving Complete Renal Response (CRR) at week 24 in the absence of renal flares",
                    "description": "Part 1: To evaluate the proportion of patients achieving complete renal response with iptacopan treatment \"A\" plus standard of care, compared to treatment alone Part 2: To evaluate the proportion of patients achieving complete renal response with Iptacopan treatment \"B\" plus standard of care, compared to treatment \"D\" alone Part 2: To evaluate the proportion of patients achieving complete renal response with Iptacopan treatment \"C\" plus standard of care, compared to treatment \"D\" alone\n\nComplete Renal Response is defined as meeting the following criteria: estimated glomerular filtration rate (eGFR) \u2265 90 mL/min/1.73 m2 or no less than 85% of baseline value, and 24h urine protein-to-creatinine ratio (UPCR) \u2264 0.5 g/g.",
                    "timeFrame": "Baseline and week 24"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Parts 1 and 2: Proportion of patients achieving CRR or PRR in the absence of renal flares",
                    "description": "Proportion of patients achieving complete renal response or partial renal response",
                    "timeFrame": "Baseline, week 24, week 52"
                },
                {
                    "measure": "Proportion of patients achieving \u226525% UPCR reduction in the absence of renal flares compared to baseline at week 24",
                    "description": "Frequency of renal flares between weeks 24 and 52",
                    "timeFrame": "Baseline, week 24 week 52"
                },
                {
                    "measure": "Log-transformed ratio to baseline of 24h UPCR at week 24",
                    "description": "Dose exposure response for reduction in proteinurea. (each 24h urine protein-to-creatinine ratio value will based on two 24 urine collections sampled within 10 days before the respective study visit)",
                    "timeFrame": "Baseline week 24"
                },
                {
                    "measure": "Change from baseline FACIT-Fatigue Score",
                    "description": "Measure fatigue in patients",
                    "timeFrame": "Weeks 24 and 52"
                },
                {
                    "measure": "Change from baseline in SLEDAI-2K score at weeks 24 and 52",
                    "description": "Measure disease activity in SLE",
                    "timeFrame": "Weeks 24 and 52"
                },
                {
                    "measure": "Change from baseline in BILAG-2004 score at weeks 24 and 52",
                    "description": "Measure disease activity",
                    "timeFrame": "Weeks 24 and 52"
                },
                {
                    "measure": "Time-to-Complete Renal Response (CRR) based on first morning void(FMV) urine samples",
                    "description": "Measurement of time to complete renal response based on urine samples",
                    "timeFrame": "Week 24 and Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\nUnequivocally positive ANA test result and/or a positive anti dsDNA at screening Active biopsy-proven lupus nephritis within 3 months of screening demonstrating Class III or IV lupus nephritis with or without co-existing features of Class V lupus nephritis.\n\nDocumentation of active renal disease at the time of screening necessitating the commencement of therapy with corticosteroids in combination with MMF/MPS.\n\neGFR \u2265 30 ml/min/1.73 m2 Vaccination against Neisseria meningitidis and Streptococcus pneumoniae infections Vaccination against Haemophilus influenzae infection Supportive care including stable dose regimen of anti-malarials (e.g. hydroxychloroquine) unless contraindicated, ACEi or ARB at either locally approved maximal daily dose or the maximally tolerated dose (per investigators' judgement) at screening, as per the local clinical practice. Doses should remain stable throughout the study.\n\nFirst presentation or flare of lupus nephritis.\n\nExclusion Criteria:\n\nInduction treatment with cyclophosphamide within 3 months of planned treatment for this study; treatment with calcineurin inhibitors within the previous 3 months prior to screening Presence of rapidly progressive glomerulonephritis (RPGN) as defined by 50% decline in eGFR within 3 months prior to screening.\n\nRenal biopsy presenting with interstitial fibrosis/tubular atrophy (IF/TA) or glomerulosclerosis of more than 50%, or which in the opinion of the investigator is such that it precludes likely response to immunosuppressive therapy.\n\nParticipants being treated with systemic corticosteroids (\\>5 mg/day prednisone or equivalent) for indications other than SLE or LN e.g. acute asthma, inflammatory bowel disease.\n\nParticipants being treated with systemic corticosteroids for SLE or LN will be excluded if they have taken more than an average of 10 mg/day prednisone (or equivalent) in the previous 4 weeks and more than an average of 20 mg/day in the previous 1 week Receipt of more than a total dose of 1000 mg equivalent i.v. pulse methylprednisolone (cumulative dose) within 2 weeks prior to enrollment (and at enrollment)\n\nOther protocol-defined inclusion/exclusion criteria may apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "1-888-669-6682",
                    "email": "novartis.email@novartis.com"
                },
                {
                    "name": "Novartis Pharmaceuticals",
                    "role": "CONTACT",
                    "phone": "+41613241111"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Novartis Pharmaceuticals",
                    "affiliation": "Novartis Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Hinsdale",
                    "state": "Illinois",
                    "zip": "60521",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.80086,
                        "lon": -87.93701
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sao Paulo",
                    "state": "SP",
                    "zip": "05403 000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "zip": "100034",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "zip": "430022",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Marseille",
                    "zip": "13385",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Nantes Cedex 1",
                    "zip": "44093",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75015",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Strasbourg Cedex",
                    "zip": "67091",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.58392,
                        "lon": 7.74553
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Berlin",
                    "zip": "13353",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.52437,
                        "lon": 13.41053
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Frankfurt",
                    "zip": "60590",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 50.11552,
                        "lon": 8.68417
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Muenchen",
                    "zip": "81377",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 51.60698,
                        "lon": 13.31243
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Pokfulam",
                    "country": "Hong Kong"
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Debrecen",
                    "zip": "4032",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.53333,
                        "lon": 21.63333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Vellore",
                    "state": "Tamil Nadu",
                    "zip": "632004",
                    "country": "India",
                    "geoPoint": {
                        "lat": 12.9184,
                        "lon": 79.13255
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "New Delhi",
                    "zip": "110029",
                    "country": "India",
                    "geoPoint": {
                        "lat": 28.63576,
                        "lon": 77.22445
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Puducherry",
                    "zip": "607403",
                    "country": "India",
                    "geoPoint": {
                        "lat": 11.93381,
                        "lon": 79.82979
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Ashkelon",
                    "zip": "78278",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.66926,
                        "lon": 34.57149
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "zip": "52621",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Kuantan",
                    "state": "Pahang",
                    "zip": "25100",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 3.8077,
                        "lon": 103.326
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Taiping",
                    "state": "Perak",
                    "zip": "34000",
                    "country": "Malaysia",
                    "geoPoint": {
                        "lat": 4.85,
                        "lon": 100.73333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Selangor Darul Ehsan",
                    "zip": "68100",
                    "country": "Malaysia"
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Tampico",
                    "state": "Tamaulipas",
                    "zip": "8944",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 22.26695,
                        "lon": -97.86815
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Merida",
                    "state": "Yucatan",
                    "zip": "97070",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 20.97537,
                        "lon": -89.61696
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Veracruz",
                    "zip": "91900",
                    "country": "Mexico",
                    "geoPoint": {
                        "lat": 19.18095,
                        "lon": -96.1429
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Carnaxide - Linda-A-Velha",
                    "state": "Lisboa",
                    "zip": "2790-134",
                    "country": "Portugal"
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Lisboa",
                    "zip": "1600190",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 38.71667,
                        "lon": -9.13333
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Vila Nova de Gaia",
                    "zip": "4434 502",
                    "country": "Portugal",
                    "geoPoint": {
                        "lat": 41.13363,
                        "lon": -8.61742
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "San Juan",
                    "zip": "00927",
                    "country": "Puerto Rico",
                    "geoPoint": {
                        "lat": 18.46633,
                        "lon": -66.10572
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Singapore",
                    "zip": "308433",
                    "country": "Singapore",
                    "geoPoint": {
                        "lat": 1.28967,
                        "lon": 103.85007
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "state": "Andalucia",
                    "zip": "41009",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Bursa",
                    "state": "Gorukle",
                    "zip": "16059",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 40.19559,
                        "lon": 29.06013
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06560",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34093",
                    "country": "Turkey",
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Novartis Investigative Site",
                    "status": "RECRUITING",
                    "city": "Talas / Kayseri",
                    "zip": "38039",
                    "country": "Turkey"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations. This trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009393",
                    "term": "Nephritis"
                },
                {
                    "id": "D000008181",
                    "term": "Lupus Nephritis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000005921",
                    "term": "Glomerulonephritis"
                },
                {
                    "id": "D000008180",
                    "term": "Lupus Erythematosus, Systemic"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12338",
                    "name": "Nephritis",
                    "asFound": "Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11178",
                    "name": "Lupus Nephritis",
                    "asFound": "Lupus Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14368",
                    "name": "Proteinuria",
                    "relevance": "LOW"
                },
                {
                    "id": "M11177",
                    "name": "Lupus Erythematosus, Systemic",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9031",
                    "name": "Glomerulonephritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3523",
                    "name": "Lupus Nephritis",
                    "asFound": "Lupus Nephritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2525",
                    "name": "Glomerulonephritis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}